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Allogeneic hematopoietic cell transplant (allo-HCT) repre-
sents the only known treatment that can offer a cure for
various hematologic malignancies [1,2]. However, morbidity
from the procedure remains a significant concern. One
major source of morbidity is the development of serious
viral infections, such as cytomegalovirus (CMV) and
Epstein–Barr virus (EBV), among others [3,4]. Strategies
to monitor these infections, namely, preemptive therapy
for CMV as well as close surveillance of EBV in the setting
of T-cell depletion have reduced the incidence of CMV dis-
ease, as well as the development of EBV-related posttrans-
plant lymphoproliferative disorders [3,5]. The occurrence of
Coxsackie-virus infection in the setting of allo-HCT, how-
ever, is an exceedingly rare complication based on available
published literature. Here, we summarize a rare presenta-tion of Coxsackie B3-associated pericardial effusion in the
setting of allo-HCT, and highlight this potentially serious
and life-threatening complication.
Case report
We present the case of a 56-year-old man who was diag-
nosed with peripheral T-cell lymphoma, not otherwise
specified. His initial staging workup using positron emission
tomography/computed tomography (PET/CT) images
showed a mass extending from the base of the tongue
and displacing the epiglottis posteriorly, as well as
hypermetabolic lymph nodes in the neck region. The
bone-marrow (BM) aspirate, biopsy, flow cytometry, and
cytogenetic analysis were negative for T-cell lymphoma
involvement. He underwent tonsillectomy, septoplasty,
and inferior turbinate resection. The pathology disclosed
a diffuse proliferation of small- to medium-size lympho-
cytes, positive for CD3, CD4, and CD5, and negative for
CD30 and CD56. The immunohistochemistry showed
abnormal T-cells positive for CD3, CD4, CD43, and CD45RO,
and negative for CD8 and CD20. The T-cell receptor gene
Pericarditis and tamponade in cell allograft 83rearrangement studies were positive. He was treated with
six cycles of dose-dense cyclophosphamide, doxorubicin,
vincristine, and prednisone. A repeat PET/CT after three
cycles showed complete metabolic response. After comple-
tion of the prescribed chemotherapy, he received involved-
field radiation therapy with a cumulative dose of 30 Gy. He
remained in complete response for approximately 5 years,
after which he was found to have bilateral symmetric
intense uptake in the nasopharynx and posterior tongue
on PET/CT. Biopsy of the nasopharynx revealed an abnor-
mal T-cell population on flow cytometry, positive for CD2,
CD3, CD4, CD5, and CD7. Ki-67 index was 40%, consistent
with the disease relapse. A repeated BM analysis was again
negative for involvement with lymphoma. The patient ini-
tially declined therapy. Eight months later, he presented
with a progressive disease, notably hypermetabolic
lymphadenopathy on both sides of the diaphragm. Flow
cytometry of the peripheral blood showed circulating
lymphocytes with aberrant phenotype, and a BM biopsy
was once again negative for lymphoma. He completed
two cycles of salvage chemotherapy with etoposide,
methylprednisolone, cytarabine, and cisplatin, along with
intrathecal methotrexate and three courses of romidepsin,
achieving a partial remission.
He underwent an allogeneic peripheral-blood stem-cell
transplant from a matched-related donor (8/8, human
leukocyte antigen A,B,C and DRB1), following a preparative
regimen of fludarabine plus pharmacokinetically targeted
intravenous busulfan (area under the curve: 3500 lmol/
min/L per dose  4 doses) and acute graft-versus-host dis-
ease (GVHD) prophylaxis consisting of tacrolimus and
mycophenolate mofetil. On Day +44 from allo-HCT, he pre-
sented with dyspnea and severe chest pain radiating to the
left arm without signs of apparent hemodynamic compro-
mise. The electrocardiogram showed unspecific repolariza-
tion changes, and serial cardiac enzymes were within
normal levels. A small pericardial effusion was evident on
transthoracic echocardiogram, supporting the diagnosis ofFig. 1 Computerized tomography of the chest. The solid arrow in
effusion.pericarditis. The peripheral blood was tested for Coxsackie
B1–B6, and quantitative serology results were positive for
Coxsackie B3 (1:80). The results of other B-serotypes of Cox-
sackie were as follows: B1 < 1:10, B2 1:10, B4 1:40,
B5 < 1:10, and B6 < 1:10. The C-reactive protein was
elevated. He was started on colchicine. Two weeks later,
he presented with a large left pleural effusion (Fig. 1). A
repeat echocardiogram confirmed worsening pericardial
effusion with evidence of early diastolic right-atrium col-
lapse (not shown). He underwent a subxiphoid pericardial
catheter insertion, and placement of a left-sided chest tube
and a pericardial window. The pathology from the peri-
cardium and the cytology from the drained pleural and peri-
cardial fluids were all negative for lymphoma. The
pericardial fluid tested negative for Gram stain, bacterial
cultures, fungal cultures, and acid-fast bacilli. His postoper-
ative course was uneventful, and he was discharged from the
hospital 5 days later on colchicine for a total of 4 weeks. His
symptoms resolved and he remains asymptomatic at the
most recent follow-up on day +152 postallografting.Discussion
This case highlights a unique presentation of pleuroperi-
carditis with cardiac tamponade from Coxsackie B3 in an
adult patient following an allo-HCT. The serologic titers
were unremarkable for other Coxsackie B serotypes, sug-
gesting that Coxsackie B3 was the most likely pathogen. A
possible limitation of our findings is the absence of poly-
merase chain reaction as an additional confirmatory test.
However, one might argue that the potential advantage of
a polymerase-chain-reaction testing would be mainly attri-
butable to increasing sensitivity of detection. Three large
studies have shown that in 78–86% of cases the causative
agent of acute pericarditis remained idiopathic [6–8]. It is
presumed that a large majority of these cases were due to
undiagnosed viral etiologies.dicates pericardial effusion. The dotted arrow indicates pleural
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84 J. El-Asmar et al.Although similar cardiac events have been described in
the literature as manifestations of transplant-associated
toxicities or less commonly GVHD, to the best of our knowl-
edge this is the first case that identifies Coxsackie B3 as the
causative agent. The occurrence of Coxsackie-virus infec-
tion in the setting of allo-HCT is not a commonly known com-
plication based on available published literature. Coxsackie
B3 virus is a cytolytic enterovirus that can cause severe car-
diac injury in the setting of myocarditis and pericarditis.
Estrin and Huber [9] investigated the inflammatory patho-
physiology of cardiac damage in myocarditis to explain why
immunosuppressive drugs fail to prevent myocarditis. The
authors concluded that Coxsackie B3 virus induces immuno-
suppressant-resistant cytokine production by helper T-cells.
The development of pericardial effusion in the setting of
allo-HCT has been described in association with GVHD [10].
Norkin et al. [11] described a series of seven cases of large
pericardial effusion out of 858 adult patients who underwent
a hematopoietic cell transplant (HCT) (autologous = 512,
allogeneic = 346) from a single institution. All but one
required a pericardial window, and nonspecific inflammatory
changes were described in six patients who underwent a
pericardial biopsy. Six of them had a preceding GVHD [11].
Although following allo-HCT, cardiac complications in the
setting of GVHD occur in less than 1% of patients [11],
pericardial effusions and cardiac tamponade are rare, yet
life-threatening manifestations of GVHD [12]. Table 1
summarizes previously described cases of patients who
developed pericardial effusions following HCT.
Several risk factors are implicated in the development of
pericardial effusions, which are not immune mediated [11].
Chemotherapy regimens consisting of anthracycline, etopo-
side, or cyclophosphamide have been associated with peri-
cardial damage when used in the conditioning phase before
HCT [13], mainly via generating cardiotoxic reactive oxygen
species [14]. Infective pericarditis with viral, bacterial, or
fungal organisms is also consequently a risk factor for peri-
cardial effusion and cardiac tamponade [15]. It is important
to keep in mind that, in the setting of immunosuppression,
infective pericarditis may progress in the absence of fever
[16]. Additionally, radiation therapy involving the medi-
astinum may contribute to cardiac toxicity [11].
Holbro et al. [17] described the case of a young patient
who developed pericardial effusion, which progressed to
cardiac tamponade between Day +19 and Day +28 following
allo-HCT, and her symptoms recurred on Day +35. Despite
pericardial fluid positivity for human herpesvirus 6, the authors
attributed her complications to sirolimus, with an unclear
pathophysiology. Other described causes include fluid over-
load posttransplant, iron overload from blood transfusions,
disease relapse, or no clear etiology in some cases [15,18].
Conclusion
Our report aims to increase awareness of the occurrence of
Coxsackie-associated life-threatening pericarditis, as well
as cardiac tamponade in adult patients undergoing allo-
HCT. This certainly remains a rare complication, yet a
life-threatening one that must be recognized early on to
allow for timely intervention. Given the numerous compli-
cations that occur following allo-HCT, it is at times
Pericarditis and tamponade in cell allograft 85challenging to determine the specific etiology, and at the
same time identify which of these pose the greatest risk
to the development of a complicated pericardial effusion.
While many characteristics of pericarditis in the setting of
allo-HCT would suggest an association with GHVD [15], it
is imperative to rule out infectious etiologies, such as Cox-
sackie B virus, as in our case.
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